Home
Life Sciences

Sector: Life Sciences

Huawei, Intel among big firms selling patents in June-recorded transactions

Two deals could bring NPE risk but others stem from bankruptcies, buying and selling of business units and company product collaborations

Historic moment as UPC hands down two full decisions within 24 hours of each other

The Unified Patent Court has handed patentees a win and a loss in its first on-the-merits rulings

Pharma patent litigation highlights in Southeast Asia in early 2020s

Rouse highlights some of the most important pharma patent decisions issued by Southeast Asian courts in the past four years

Latest content

BioNTech facing fresh mRNA spat in vaccine patent royalties dispute

The covid-19 IP war’s most prolific defendant finds itself on the brink of litigation in another fight

27 March 2024

Broad Institute gets huge CRISPR boost from Board of Appeal decision

Many applicants could benefit from the EPO’s latest appellate decision on priority entitlement

26 March 2024

Singapore’s pro-patentee pharma landscape facing key legislative changes

The country's patent linkage system offers significant advantages to drug patentees, but proposed law amendments threaten to change that

26 March 2024

Regeneron and Novartis dispute leads Second Circuit to reject creation of new patent standard

A lower court improperly invented a rule preventing plaintiffs from challenging anticompetitive harm to a market encompassed entirely by a patent, the US Court of Appeals for the Second Circuit has said

19 March 2024

Meet the woman challenging South Korean norms by driving value through patents

“IP is everything for the innovation of science,” Sue Soheui Choe, founder and IP head of biotech start-up Atheon Bio, tells IAM

13 March 2024

Analysis shows trade secret litigation is being “brutally hard fought” – and companies must prepare

IAM has launched a specialist trade secrets hub providing practical and timely guidance for practitioners trying to navigate this fast-moving space

07 March 2024

Patent transactions in Q4 2023

Featured in Secondary Market Activity

AST’s most recent patent deals report measures an uptick in activity in the US patent secondary market

07 March 2024

Sweden: Trade secrets – policy and latest developments

Featured in Trade Secrets Hub 2024

Trade secrets are an effective means to complement and supplement patent portfolios, because they can be an effective way to protect gaps that patents cannot fill. However, the pace at which tech is being employed in Sweden has hugely increased the risk of trade secrets being breached.

07 March 2024

Landmark ruling in pharma appeal cements scope of product-by-process claims

A Delhi High Court division bench has outlined that patent protection deriving from product-by-process claims will extend to the product itself, provided it is novel and inventive. This judgment provides much-needed clarity on an issue that was sorely lacking elucidation in Indian jurisprudence.

06 March 2024

Amgen’s UPC battles could bring consolation at the end of decade-long PCSK9 war

The company will be looking to make up for the terrible reversal of fortunes it has suffered in long-running spat with Sanofi and Regeneron

29 February 2024

Unlock unlimited access to all IAM content